Clinical Trial Update: First-line Treatment of Advanced/unresectable DDLPS [Phase 2]

View source ↗

Summary

This clinical trial update outlines a Phase 2 first-line treatment study for advanced or unresectable dedifferentiated liposarcoma (DDLPS) and soft tissue sarco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dedifferentiated Liposarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Not disclosed

Snippet

Sponsor: Fudan University | Conditions: Dedifferentiated Liposarcoma, Soft Tissue Sarcoma (STS) | Phase 2 | Status: NOT_YET_RECRUITING